Brenntag’s Separation Gamble Faces a Market That Just Won’t Cooperate
19.06.2026 - 18:24:25 | boerse-global.de
Europe’s largest chemical distributor saw its shares claw back a fraction of recent losses on Friday, but the relief looks fragile. Brenntag edged up nearly 1 percent to EUR 54.36, a tentative bounce after a punishing session on Thursday that wiped more than 3 percent off the stock alongside peers BASF and Evonik. The move does little to mask a deeper malaise: over the past month Brenntag has shed roughly 8 percent of its value, sliding below its 100-day moving average of EUR 55.73 in the process.
The headwinds are structural, not cyclical. Germany’s chemical industry association, the VCI, reported a seasonally adjusted production drop of 2.8 percent in the first quarter of 2026, with output down nearly 6 percent year-on-year. Capacity utilization is stuck at 75.1 percent, a level the VCI describes as structurally unprofitable. Rising crude oil prices are compounding the pressure at Brenntag, which trades a heavy volume of oil-linked commodity chemicals. The result is a tightening margin squeeze that is now forcing management to move faster than originally planned.
Brenntag’s own first-quarter numbers laid bare the strain. Revenue came in at EUR 3.66 billion, missing the consensus estimate of EUR 3.69 billion, while earnings per share of EUR 0.68 fell well short of the EUR 0.805 analysts had expected. To offset the slide, the company is accelerating a cost-cutting drive that saved EUR 27 million in the first quarter alone, targeting annual savings of EUR 200 million to EUR 250 million by 2027. The gross margin ticked up modestly to 25.9 percent, offering a thin buffer but no cure for the wider demand drought.
Should investors sell immediately? Or is it worth buying Brenntag?
The board’s biggest strategic move is the separation of the Essentials and Specialties divisions, a restructuring designed to sharpen efficiency and stop the erosion of pricing power in basic chemicals. The market has yet to reward the plan. With the relative strength index hovering at 37 — still above the oversold threshold of 30 but trending lower — the technical picture offers little comfort. The 200-day moving average at EUR 52.65 remains the crucial floor. A break below that level would open the path toward EUR 50 and confirm that the long-term uptrend has cracked.
Until then, Brenntag is relying on its existing full-year guidance to anchor investor sentiment: operating EBITDA between EUR 1.15 billion and EUR 1.35 billion. Whether that range holds depends on whether the restructuring gains traction before the market weakens further. The next major checkpoint comes in August, when the company publishes detailed second-quarter figures. For now, the stock is stuck in a holding pattern — waiting for either a catalyst or a breakdown.
Ad
Brenntag Stock: New Analysis - 19 June
Fresh Brenntag information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
